Reg. no. 5594392259 · Research and experimental development on biotechnology · SOLNA
IONLACE AB is registered with the legal form Limited company, is based in SOLNA and is active in Research and experimental development on biotechnology. Revenue for 2025 was 14.7 MSEK.
Fiscal year ending 2025-12-31 · Amounts in SEK
Net revenue
14.7 MSEK
▼ −1%Operating result
-3.8 MSEK
▼ −327%Net result
-4.2 MSEK
▼ −404%Employees (annual report)
9
Total assets
5.1 MSEK
Equity
1.6 MSEK
Equity ratio
31 %
Profit margin
−28.3 %
MSEK
IONLACE AB posted a loss in 2025: the net result was -4.2 MSEK, against 1.4 MSEK the period before. IONLACE AB reported an operating margin of -26.1 % in 2025, down from 11.4 %. Net sales per employee came to roughly 1.6 MSEK for 2025.
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
IONLACE AB's reg. no. is 5594392259.
IONLACE AB reported revenue of 14.7 MSEK for the fiscal year 2025.
No — IONLACE AB reported a net result of -4.2 MSEK for 2025.
IONLACE AB had 9 employees as of the most recently reported period (2025).
IONLACE AB is registered under Research and experimental development on biotechnology.
IONLACE AB is based in SOLNA.